Health ❯ Medicine

Pharmaceuticals

Drug Development Weight Loss Weight Loss Drugs Clinical Trials Diabetes Acetaminophen Pain Relief Drug Safety Drug Approval Over-the-Counter Medications Antibiotics Abortion Pregnancy GLP-1 Drugs Side Effects Weight Loss Medications Obesity Weight-loss Drugs Cannabis Cancer Treatment Pain Management Paracetamol Diabetes Treatment Pain Relievers Insulin Weight-Loss Drugs Veterinary Medicine Abortion Drugs Weight Management Autism Obesity Drugs Drug Pricing Contraceptives Semaglutide Supplements Drug Side Effects Drug Trials Abortion Pill Vaccines Erectile Dysfunction Oncology Neurology Antiviral Drugs Obesity Treatments Over-the-Counter Drugs Obesity Treatment Counterfeit Drugs Diabetes Medication Alzheimer's Disease FDA Approval Prescription Drugs Dietary Supplements Recalls Cancer Doping Substances Regulations Vaccine Development Mifepristone Biotechnology Weight-loss drugs Drug Use Inhalers HIV/AIDS Contraception Drug Regulation Biopharma Painkillers Drug Discovery HIV Prevention Diabetes Medications Abortion-Inducing Drugs FDA Regulations Product Safety Drug Formulation Birth Control Allergy Treatment Therapies Eye Care Adverse Effects Safety Opioids Contamination Viagra Demand Forecasting Clonazepam Amyloid Plaques Experimental Drugs Pfizer Allergy Medications Potassium Chloride Comorbidities Clinical-stage Therapies Drug Comparison Drug Approvals Marine-Derived Compounds Hydroxychloroquine Policy Solutions Anti-aging Immunosuppressants Economics

Pharvaris’ Oral HAE Drug Deucrictibant Delivers Rapid Relief in Pivotal Phase 3

The company aims to file for FDA approval in the first half of 2026.

Novo Nordisk’s Oral Semaglutide Fails to Slow Alzheimer’s in Dual Phase 3 Trials

Terry Dubrow Claims GLP-1 Weight Loss Can Produce an 'Ozempic Penis'

Low-Dose Colchicine Lowers Heart Attack and Stroke Risk in Heart Disease, Cochrane Review Finds

Merck to Buy Cidara for $9.2 Billion to Secure Long-Acting Flu Drug

First New Antimalarial in Decades Tops 97% Cure in Phase III as Novartis Seeks Approval

Merck’s Oral PCSK9 Pill Matches Injectables in Phase 3, Setting Up 2026 FDA Bid

Officials Urge Caution on Tylenol in Pregnancy as Texas Sues and Voters Weigh In

Kennedy Says Evidence Is Not Sufficient to Link Tylenol to Autism

Texas Sues J&J and Kenvue Over Tylenol Marketing to Pregnant Women, Citing Autism Risk

South Africa Approves Twice-Yearly HIV Prevention Shot, Clearing Path to 2026 Rollout

Ascend Recalls 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures

FDA Reapproves GSK’s Blenrep for Multiple Myeloma in Narrow Combination Use

Kenvue Asks FDA to Reject Autism Warning on Tylenol in Pregnancy

J&J Documents Undercut Tylenol–Autism Allegations as Viral Report Faces New Scrutiny

FDA Reviews Tylenol Label as WHO Rejects Claims of Prenatal Link to Autism

FDA Moves to Add Pregnancy Warning on Acetaminophen as Experts Counter Link to Autism

FDA Clears Second Generic Mifepristone as White House Cites Legal Duty

FDA Opens Tylenol Label Review as Scientists and Global Regulators Reject Autism Claim

Cannabis Extract VER-01 Eases Chronic Low Back Pain in Phase 3 Trial